MYCN-amplified stage 1 neuroblastoma: results of a retrospective multicenter study

MLA

M. B. Belogurova, et al. “MYCN-Amplified Stage 1 Neuroblastoma: Results of a Retrospective Multicenter Study.” Pediatric Hematology/Oncology and Immunopathology, vol. 21, Dec. 2022, pp. 45–52. EBSCOhost, https://doi.org/10.24287/1726-1708-2022-21-4-45-52.

APA

M. B. Belogurova, T. V. Kotlyarova, D. Y. Kachanov, L. G. Fechina, A. N. Zaychikov, E. S. Mitrofanova, A. S. Slinin, & T. V. Shamanskaya. (2022). MYCN-amplified stage 1 neuroblastoma: results of a retrospective multicenter study. Pediatric Hematology/Oncology and Immunopathology, 21, 45–52. https://doi.org/10.24287/1726-1708-2022-21-4-45-52

Chicago

M. B. Belogurova, T. V. Kotlyarova, D. Y. Kachanov, L. G. Fechina, A. N. Zaychikov, E. S. Mitrofanova, A. S. Slinin, and T. V. Shamanskaya. 2022. “MYCN-Amplified Stage 1 Neuroblastoma: Results of a Retrospective Multicenter Study.” Pediatric Hematology/Oncology and Immunopathology 21 (December): 45–52. doi:10.24287/1726-1708-2022-21-4-45-52.